Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2018 Dec 5;8(2):e1546544. doi: 10.1080/2162402X.2018.1546544

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

This work was authored as part of the Contributor’s official duties as an Employee of the United States Government and is therefore a work of the United States Government. In accordance with 17 U.S.C. 105, no copyright protection is available for such works under U.S. Law.

This is an Open Access article that has been identified as being free of known restrictions under copyright law, including all related and neighboring rights (https://creativecommons.org/publicdomain/mark/1.0/). You can copy, modify, distribute and perform the work, even for commercial purposes, all without asking permission.

PMC Copyright notice

Figure 2. — Effect of Pom on cellular IKZF1, IRF4 and MHC-I in MT-2 cells and TLOM1 cells. Immunoblots for IKZF1, IRF4 and beta actin in MT-2 cells (A) or TLOM1 cells (B) treated for 10 days with 10 µM Pom or DMSO control. Relative protein levels for IRF4 and MHC-I were determined based on the loading controls (beta-actin or tubulin) using the Licor system and the relative values are shown below the images.